The Library
Vaccination and healthy ageing : how to make life-course vaccination a successful public health strategy
Tools
Tools
Tools
Michel, J. -P., Gusmano, M., Blank, P.R. and Philp, Ian (2010) Vaccination and healthy ageing : how to make life-course vaccination a successful public health strategy. European Geriatric Medicine, Vol.1 (No.3). pp. 155-165. doi:10.1016/j.eurger.2010.03.013 ISSN 18787649.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1016/j.eurger.2010.03.013
Abstract
Vaccine guidelines that advocate immunisation in adults aged >= 60 years and an international policy brief that explores the importance of life-course vaccination have been proposed. The guidelines, policy brief and associated data were considered by experts at two meetings during 2009. This paper amalgamates those discussions and recommends practical strategies that may contribute to the successful implementation of adult vaccination. The challenges posed by changes in the global age distribution may be confronted by preparing for healthy ageing early in life - a 'life-course' approach to health. Vaccination can provide cost-effective protection against a host of diseases throughout life, but remains an underused public-health strategy in adults for the promotion of healthy ageing. Without specific vaccination programmes for the adult population aged >= 50 years ('50+ vaccine programmes') infectious diseases will continue to be a cause of substantial morbidity and mortality in late adulthood. The reasons for low vaccination rates among adults ('what we know') are identified and the four common determinants for the successful implementation of 50+ vaccination programmes ('what we should do') are examined: vaccination programme objectives, the role of healthcare professionals, access to vaccines, and public awareness. To achieve the goal of healthy ageing, nationally customised measures should be instigated to address these determinants in the 50+ age group and to ensure access to vaccination for those who are expected to benefit. (C) 2010 Elsevier Masson SAS and European Union Geriatric Medicine Society. All rights reserved.
| Item Type: | Journal Article | ||||
|---|---|---|---|---|---|
| Subjects: | R Medicine > R Medicine (General) R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine |
||||
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School | ||||
| Library of Congress Subject Headings (LCSH): | Vaccination, Aging, Medical policy, Immunization, Age distribution (Demography), Older people -- Health and hygiene | ||||
| Journal or Publication Title: | European Geriatric Medicine | ||||
| Publisher: | Elsevier Ltd | ||||
| ISSN: | 18787649 | ||||
| Official Date: | June 2010 | ||||
| Dates: |
|
||||
| Volume: | Vol.1 | ||||
| Number: | No.3 | ||||
| Page Range: | pp. 155-165 | ||||
| DOI: | 10.1016/j.eurger.2010.03.013 | ||||
| Status: | Not Peer Reviewed | ||||
| Publication Status: | Published | ||||
| Access rights to Published version: | Restricted or Subscription Access | ||||
| Funder: | Merck Sharp & Dohme, Sanofi Pasteur MSD, , |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
